These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27037683)

  • 1. Long-term human primary hepatocyte cultures in a microfluidic liver biochip show maintenance of mRNA levels and higher drug metabolism compared with Petri cultures.
    Jellali R; Bricks T; Jacques S; Fleury MJ; Paullier P; Merlier F; Leclerc E
    Biopharm Drug Dispos; 2016 Jul; 37(5):264-75. PubMed ID: 27037683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of expression and activity levels of primary rat hepatocyte detoxication genes under various flow rates and cell densities in microfluidic biochips.
    Baudoin R; Alberto G; Legendre A; Paullier P; Naudot M; Fleury MJ; Jacques S; Griscom L; Leclerc E
    Biotechnol Prog; 2014; 30(2):401-10. PubMed ID: 24376233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes.
    Cho YY; Jeong HU; Kim JH; Lee HS
    Drug Des Devel Ther; 2014; 8():2137-45. PubMed ID: 25395831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the metabolic capability of primary human hepatocytes in three-dimensional cultures on microstructural plates.
    Koyama S; Arakawa H; Itoh M; Masuda N; Yano K; Kojima H; Ogihara T
    Biopharm Drug Dispos; 2018 Apr; 39(4):187-195. PubMed ID: 29469947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a liver microfluidic biochip to predict in vivo clearances of seven drugs in rats.
    Baudoin R; Legendre A; Jacques S; Cotton J; Bois F; Leclerc E
    J Pharm Sci; 2014 Feb; 103(2):706-18. PubMed ID: 24338834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of seven drug metabolisms and clearances by cryopreserved human primary hepatocytes cultivated in microfluidic biochips.
    Baudoin R; Prot JM; Nicolas G; Brocheton J; Brochot C; Legallais C; Benech H; Leclerc E
    Xenobiotica; 2013 Feb; 43(2):140-52. PubMed ID: 22830982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening.
    Prot JM; Videau O; Brochot C; Legallais C; Bénech H; Leclerc E
    Int J Pharm; 2011 Apr; 408(1-2):67-75. PubMed ID: 21295126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized protocol for the hepatic differentiation of induced pluripotent stem cells in a fluidic microenvironment.
    Danoy M; Bernier ML; Kimura K; Poulain S; Kato S; Mori D; Kido T; Plessy C; Kusuhara H; Miyajima A; Sakai Y; Leclerc E
    Biotechnol Bioeng; 2019 Jul; 116(7):1762-1776. PubMed ID: 30883676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-free culture of primary human hepatocytes in a miniaturized hollow-fibre membrane bioreactor for pharmacological in vitro studies.
    Lübberstedt M; Müller-Vieira U; Biemel KM; Darnell M; Hoffmann SA; Knöspel F; Wönne EC; Knobeloch D; Nüssler AK; Gerlach JC; Andersson TB; Zeilinger K
    J Tissue Eng Regen Med; 2015 Sep; 9(9):1017-26. PubMed ID: 23165723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies.
    Hoffmann SA; Müller-Vieira U; Biemel K; Knobeloch D; Heydel S; Lübberstedt M; Nüssler AK; Andersson TB; Gerlach JC; Zeilinger K
    Biotechnol Bioeng; 2012 Dec; 109(12):3172-81. PubMed ID: 22688505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic characterization of primary rat hepatocytes cultivated in parallel microfluidic biochips.
    Legendre A; Baudoin R; Alberto G; Paullier P; Naudot M; Bricks T; Brocheton J; Jacques S; Cotton J; Leclerc E
    J Pharm Sci; 2013 Sep; 102(9):3264-76. PubMed ID: 23423727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing.
    Tostões RM; Leite SB; Serra M; Jensen J; Björquist P; Carrondo MJ; Brito C; Alves PM
    Hepatology; 2012 Apr; 55(4):1227-36. PubMed ID: 22031499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional co-culture of primary human liver cells in bioreactors for in vitro drug studies: effects of the initial cell quality on the long-term maintenance of hepatocyte-specific functions.
    Zeilinger K; Sauer IM; Pless G; Strobel C; Rudzitis J; Wang A; Nüssler AK; Grebe A; Mao L; Auth SH; Unger J; Neuhaus P; Gerlach JC
    Altern Lab Anim; 2002; 30(5):525-38. PubMed ID: 12405881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Messenger RNA Expression of Albumin, Transferrin, Transthyretin, Asialoglycoprotein Receptor, Cytochrome P450 Isoform, Uptake Transporter, and Efflux Transporter Genes as a Function of Culture Duration in Prolonged Cultured Cryopreserved Human Hepatocytes as Collagen-Matrigel Sandwich Cultures: Evidence for Redifferentiation upon Prolonged Culturing.
    Yang Q; Li AP
    Drug Metab Dispos; 2021 Sep; 49(9):790-802. PubMed ID: 34135090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the hepatotoxicity of flutamide: pro-survival/apoptotic and necrotic switch in primary rat hepatocytes characterized by metabolic and transcriptomic profiles in microfluidic liver biochips.
    Legendre A; Jacques S; Dumont F; Cotton J; Paullier P; Fleury MJ; Leclerc E
    Toxicol In Vitro; 2014 Aug; 28(5):1075-87. PubMed ID: 24793618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new microfluidic platform integrating co-cultures of intestinal and liver cell lines.
    Bricks T; Paullier P; Legendre A; Fleury MJ; Zeller P; Merlier F; Anton PM; Leclerc E
    Toxicol In Vitro; 2014 Aug; 28(5):885-95. PubMed ID: 24662032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite formation kinetics and intrinsic clearance of phenacetin, tolbutamide, alprazolam, and midazolam in adenoviral cytochrome P450-transfected HepG2 cells and comparison with hepatocytes and in vivo.
    Donato MT; Hallifax D; Picazo L; Castell JV; Houston JB; Gomez-Lechón MJ; Lahoz A
    Drug Metab Dispos; 2010 Sep; 38(9):1449-55. PubMed ID: 20501911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction, expression and maintenance of cytochrome P450 isoforms in long-term cultures of primary human hepatocytes.
    Yuan J; Liu L; Shimada M; Wang A; Ruhnke M; Heeckt P; Muller AR; Nussler NC; Neuhaus P; Nussler A
    ALTEX; 2004; 21 Suppl 3():3-11. PubMed ID: 15057403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of omeprazole and phenacetin first-pass metabolism in humans using a microscale bioreactor and pharmacokinetic models.
    Bricks T; Hamon J; Fleury MJ; Jellali R; Merlier F; Herpe YE; Seyer A; Regimbeau JM; Bois F; Leclerc E
    Biopharm Drug Dispos; 2015 Jul; 36(5):275-93. PubMed ID: 25678106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.